St. Anna Children's Cancer Research Institute (CCRI)
Veveeyan Suresh is an early stage researcher at VAGABOND ITN network since March 2021 and simultaneously serves as a PhD candidate focused on the molecular biology of solid tumors at St. Anna Children's Cancer Research Institute. During the career, Veveeyan completed a VAGABOND industry secondment at MIMETAS in 2024, working on tumor invasion assays using an organ-on-a-chip model, and participated in a VAGABOND secondment at Kinderspital Zürich in 2022. Notable academic experience includes a master thesis project at Klinikum rechts der Isar der TU München and a role as a student research assistant at Biomedical center, LMU. Veveeyan obtained a Doctor of Philosophy degree in malignant diseases from the Medical University of Vienna (2021-2024), a Master of Science in cellular and molecular biology from Ludwig-Maximilians-Universität München (2018-2021), and a Bachelor's degree in biotechnology from Sri Venkateswara College of Engineering (2014-2018).
This person is not in any offices
St. Anna Children's Cancer Research Institute (CCRI)
The St. Anna Children's Cancer Research Institute (St Anna CCRI), located in the center of Vienna, the world's most livable city and one of Europe's most important places for biomedical research and life sciences, is an internationally renowned multidisciplinary research institution with the aim to develop and optimize diagnostic, prognostic, and therapeutic strategies for the treatment of children and adolescents with cancer. To achieve this goal we combine basic research with translational and clinical research and focus on the specific characteristics of childhood tumor diseases in order to provide young patients with the best possible and most innovative therapies. Dedicated research groups in the fields of tumor genomics and epigenomics, immunology, molecular biology, cell biology, bioinformatics and clinical research are working together to harmonize scientific findings with the clinical needs of physicians to ultimately improve the wellbeing of our patients. Through close cooperation between clinic and research, the CCRI provides an ideal environment for cutting-edge research and its translation into clinical practice. To achieve our ultimate goal of advancing the well-being of patients, the CCRI constantly pushes scientific boundaries and strongly promotes close collaboration and exchange with external institutions like the Medical University of Vienna, CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, the Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA) and the Institute of Molecular Pathology (IMP).